Skip to main content

Gilead Joining the Global Access to Oncology Medicines Coalition

By: 3BL Media

SOURCE: Gilead Sciences

DESCRIPTION:

We’re pleased to announce that we're joining the global Access to Oncology Medicines (ATOM) Coalition to help improve care and access to essential cancer medicines in low- and lower middle-income countries. https://gilead.inc/39Gb9nb

About Gilead

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

View original content here

Tweet me: .@GileadSciences announces they are joining the global Access to Oncology Medicines (ATOM) Coalition. Read more here: https://bit.ly/3PHkf3F

KEYWORDS: NYSE: GILD, Gilead Sciences, ATOM

"Making strides against cancer in low- and lower middle- income countries will require not only innovative therapies, but also bold strategies built on the power of partnerships and working across the continuum of care - starting from disease awareness and prevention, to diagnosis and treatment, all the way to disease management." Mike Boyd Senior Vice President Gilead logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  241.56
+0.63 (0.26%)
AAPL  260.33
-2.03 (-0.77%)
AMD  210.02
-4.33 (-2.02%)
BAC  55.64
-1.61 (-2.81%)
GOOG  322.43
+7.88 (2.51%)
META  648.69
-11.93 (-1.81%)
MSFT  483.47
+4.96 (1.04%)
NVDA  189.11
+1.87 (1.00%)
ORCL  192.84
-0.91 (-0.47%)
TSLA  431.41
-1.55 (-0.36%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.